US Patent 11129817 Solid dispersion forms of rifaximin
Patent 11129817 was granted and assigned to Salix Pharmaceuticals on September, 2021 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
February 12, 2021
0
Date of Patent
September 28, 2021
0
Patent Applicant
Patent Application Number
20210212
0
Patent Citations Received
Patent Inventor Names
Mohammed A. Kabir
0
Pam Golden
0
Patent Jurisdiction
Patent Number
Find more entities like US Patent 11129817 Solid dispersion forms of rifaximin
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
